Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Is Now the Time to Buy Astellas Pharma Inc?

02 Nov 2016 Sadif Analytics Prime 12 $25.00

Thomson Reuters Stock Report - Astellas Pharma Inc (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for ALPMF: the economy's impact on ALPMF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

01 Nov 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

"The Economy Matters" Report for ALPMY: the economy's impact on ALPMY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

01 Nov 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ASTELLAS PHARMA INC (ALPMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Value Graph: ASTELLAS PHARMA -- ALPMY

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Oct 2016 Wright Reports 65 $75.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

07 Oct 2016 GlobalData 347 $300.00

Astellas Pharma Inc.

Astellas Pharma Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report cover...

05 Oct 2016 MarketLine 49 $50.00